EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatoprotective Effects of Hyaluronic Acid-Preconditioned Bone Marrow Mesenchymal Stem Cells against Liver Toxicity via the Inhibition of Apoptosis and the Wnt/β-Catenin Signaling Pathway

Amira Awadalla, Eman T Hamam, Sally Abdallah Mostafa iD, Seham Ahmed Mahmoud, Khalid Mohamed Elazab iD, Ahmed Mohamed El Nakib, Mamdouh Eldesoqui iD, Mohamed El-Sherbiny iD, Omar A Ammar iD, Rasha Hamed Al-Serwi iD, Mohamed A Saleh iD, Amira Sarhan und 1 weitere

Cells · 2023

DOI: 10.3390/cells12111526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Amira Awadalla und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence for Genome and Cancer Research, Urology and Nephrology Center, Mansoura University, Mansoura 35516, Egypt. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Mesenchymal Stem Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Doxorubicin (DOX) is widely used to treat a variety of malignancies in both adults and children, including those of the bladder, breast, stomach, and ovaries. Despite this, it has been reported to cause hepatotoxicity. The recent discovery of bone marrow-derived mesenchymal stem cells’ (BMSCs) therapeutic effects in the context of liver diseases suggests that their administration plays a part in the mitigation and rehabilitation of drug-induced toxicities.

Objectives

This study investigated whether bone BMSCs could reduce DOX-induced liver damage by blocking the Wnt/β-catenin pathway that causes fibrotic liver. Materials and methods: BMSCs were isolated and treated with hyaluronic acid (HA) for 14 days before injection. Thirty-five mature male SD rats were categorized into four groups; group one (control) rats were supplemented with saline 0.9% for 28 days, group two (DOX) rats were injected with DOX (20 mg/kg), group three (DOX + BMSCs) rats were injected with 2 × 106 BMSCs after 4 days of DOX injection, group four (DOX + BMSCs + HA) rats were injected with 0.1 mL BMSCs pretreated with HA after 4 days of DOX. After 28 days the rats were sacrificed, and blood and liver tissue samples were subjected to biochemical and molecular analysis. Morphological and immunohistochemical observations were also carried out.

Results

In terms of liver function and antioxidant findings, cells treated with HA showed considerable improvement compared to the DOX group (p < 0.05). Moreover, the expression of inflammatory markers (TGFβ1, iNos), apoptotic markers (Bax, Bcl2), cell tracking markers (SDF1α), fibrotic markers (β-catenin, Wnt7b, FN1, VEGF, and Col-1), and ROS markers (Nrf2, HO-1) was improved in BMSCs conditioned with HA in contrast to BMSCs alone (p < 0.05).

Conclusion

Our findings proved that BMSCs treated with HA exert their paracrine therapeutic effects via their secretome, suggesting that cell-based regenerative therapies conditioned with HA may be a viable alternative to reduce hepatotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryMesenchymal Stem CellsRatsMaleAnimalsWnt Signaling PathwayRats, Sprague-Dawleybeta CateninHyaluronic AcidApoptosis

Stichwörter der Autor:innen

BMSCsDoxorubicinhepatotoxicityhyaluronic acid

Substanzen

beta CateninHyaluronic Acid

Autor:innen und Institutionen

  • Center of Excellence for Genome and Cancer Research, Urology and Nephrology Center, Mansoura University, Mansoura 35516, Egypt.
  • Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
  • Chemistry Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
  • Department of Biology, Faculty of Science, Jazan University, Jazan 82511, Saudi Arabia.
  • Department of Tropical Medicine, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
  • Department of Anatomy, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.

ORCID-Profile: Sally Abdallah Mostafa, Khalid Mohamed Elazab, Mamdouh Eldesoqui, Mohamed El-Sherbiny, Omar A Ammar, Rasha Hamed Al-Serwi, Mohamed A Saleh, Mohamed Ali

Zitieren

APA

Awadalla, A., Hamam, E. T., Mostafa, S. A., Mahmoud, S. A., Elazab, K. M., El Nakib, A. M., Eldesoqui, M., El-Sherbiny, M., Ammar, O. A., Al-Serwi, R. H., Saleh, M. A., Sarhan, A., & Ali, M. (2023). Hepatoprotective Effects of Hyaluronic Acid-Preconditioned Bone Marrow Mesenchymal Stem Cells against Liver Toxicity via the Inhibition of Apoptosis and the Wnt/β-Catenin Signaling Pathway. Cells. https://doi.org/10.3390/cells12111526

Vancouver

Awadalla A, Hamam ET, Mostafa SA, Mahmoud SA, Elazab KM, El Nakib AM, et al. Hepatoprotective Effects of Hyaluronic Acid-Preconditioned Bone Marrow Mesenchymal Stem Cells against Liver Toxicity via the Inhibition of Apoptosis and the Wnt/β-Catenin Signaling Pathway. Cells. 2023. doi:10.3390/cells12111526

BibTeX
@article{Awadalla2023,
  author = {Awadalla, Amira and Hamam, Eman T and Mostafa, Sally Abdallah and Mahmoud, Seham Ahmed and Elazab, Khalid Mohamed and El Nakib, Ahmed Mohamed and Eldesoqui, Mamdouh and El-Sherbiny, Mohamed and Ammar, Omar A and Al-Serwi, Rasha Hamed and Saleh, Mohamed A and Sarhan, Amira and Ali, Mohamed},
  title = {Hepatoprotective Effects of Hyaluronic Acid-Preconditioned Bone Marrow Mesenchymal Stem Cells against Liver Toxicity via the Inhibition of Apoptosis and the Wnt/β-Catenin Signaling Pathway},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12111526}
}
Kostenlos starten →